Abstract

The present study evaluated sociodemographic and diagnostic predictors of suicidal ideation and attempts in a nationally representative sample of preadolescent youth enrolled in the Adolescent Brain Cognitive Development Study. Rates and predictors of psychiatric treatment utilization among suicidal youth also were examined. Eleven thousand eight hundred and seventy-five 9- and 10-year-old children residing in the United States were assessed. Children and their parents/guardians provided reports of children’s lifetime history of suicidal ideation, suicide attempts, and psychiatric disorders. Parents also reported on sociodemographic characteristics and mental health service utilization. Multivariate logistic regression analyses were employed to evaluate sociodemographic and diagnostic correlates of suicidal ideation, suicide attempts among youth with suicidal ideation, and treatment utilization among youth with suicidal ideation and suicide attempts. Lifetime prevalence rates were 14.33% for suicidal ideation and 1.26% for suicide attempts. Youth who identified as male, a sexual minority, or multiracial had greater odds of suicidal ideation, and sexual minority youth and youth with a low family income had greater odds of suicide attempts. Comorbid psychopathology was associated with higher odds of both suicidal ideation and suicide attempts. In youth, 34.59% who have suicidal ideation and 54.82% who had attempted suicide received psychiatric treatment. Treatment utilization among suicidal youth was lower among those who identified as female, Black, and Hispanic. Suicidal ideation and attempts among preadolescent children are concerningly high and targeted assessment and preventative efforts are needed, especially for males, racial, ethnic, and sexual minority youth, and those youth experiencing comorbidity.

Details

Title
Prevalence and correlates of suicidal ideation and suicide attempts in preadolescent children: A US population-based study
Author
Lawrence, Hannah R 1   VIAFID ORCID Logo  ; Burke, Taylor A 2 ; Sheehan, Ana E 3 ; Pastro Brianna 1 ; Levin, Rachel Y 2   VIAFID ORCID Logo  ; Walsh Rachel F L 4 ; Bettis, Alexandra H 5   VIAFID ORCID Logo  ; Liu, Richard T 2 

 McLean Hospital, Department of Psychiatry, Belmont, USA (GRID:grid.240206.2) (ISNI:0000 0000 8795 072X); Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital, Department of Psychiatry, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924) 
 University of Delaware, Department of Psychological and Brain Sciences, Newark, USA (GRID:grid.33489.35) (ISNI:0000 0001 0454 4791) 
 Temple University, Department of Psychology, Philadelphia, USA (GRID:grid.264727.2) (ISNI:0000 0001 2248 3398) 
 Vanderbilt University Medical Center, Department of Psychiatry and Behavioral Sciences, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2575159150
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.